Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > Need PR coverage on Patient- 21 months insulin independent
View:
Post by steadfast on Jan 10, 2022 1:17pm

Need PR coverage on Patient- 21 months insulin independent

Just emailed Dr T to remind him to ensure we get coverage on CTV with
Avis Favaro, she is highly respected in the Health field and to ensure
someone contact Gina Kolata, NY Times as we have a much better story
for her than Semma gave her.  We need the IR Team letting the Press know
we have World Class News.  Hopefully, they had the NR's  circulating this morning.

If we can get good Press Coverage and get the stock back up, the Devils
have to cover their shorts.  Time to play hardball with them.
Comment by Redbaron2211 on Jan 10, 2022 1:32pm
Agree Steadfast, it takes some time to build content, but there is a bigger story here than any of our peers.  Shorts have likely mostly covered, apart from unjustified knee-jerk fear they don't have a leg to stand on.   
Comment by SmallBets on Jan 10, 2022 1:38pm
You could always forward the press release to ctv yourself...
Comment by BioTeck on Jan 10, 2022 1:48pm
You see the problem here? A bunch of investors on a BB are making suggestions for the VP of IR. They keep hiring ibecels who are clueless. They just sit back and get fat off of the DSU. I'm tired of stating what needs to be done because Spill is a class act clown who has his head so far up his rear that he'll (see Charly hiding up there) and likely ruin any opportunities we have. 
Comment by Ekenbullets on Jan 11, 2022 4:34am
Its not interesting at this point, no news outlet will pick this up so soon after Vertex took the space. I told long ago that Sernova should communicate a user perspective with testamonial from the first patient. They missed the opportunity to free world wide coverage worth millions. The Vertex news exploded in the diabetes communties around the world, it was also posted uncountable times in so ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities